
The U.S. District Court for the Western District of Pennsylvania has entered a consent decree prohibiting Ranierās Rx Laboratory Inc. from manufacturing or distributing compounded drugs until they comply with the Federal Food, Drug, and Cosmetic Act and Food and Drug Administration regulations.